• 정보처리학회논문지:소프트웨어 및 데이터공학
• /
• 제3권5호
• /
• pp.187-194
• /
• 2014

전립선암은 전립선에 나타나는 악성 종양이다. 현재 그 발병률이 높아지고 있다. 전립선암의 구조를 가장 정확하게 확인할 수 있는 검사 방법은 MRI를 이용하는 것이나, 그 비용 때문에 모든 환자에게 적용하기는 어려운 실정이다. 그래서 많은 환자들은 가격이 저렴한 초음파검사를 이용하여 전립선암을 진단하고 있다. 전통적으로 의사들은 영상을 눈으로 확인하여 전립선의 경계를 수동으로 분할하였다. 그러나 수동으로 분할하는 과정은 시간이 많이 소요되며, 의사에 따라서 그 경계가 일정하지 않게 얻어진다. 이 문제를 해결하기 위하여 전립선의 자동 분할에 관한 연구가 되었고, 환자들에게 신뢰를 줄 수 있었다. 본 연구는 초음파 전립선 영상에서 전립선의 경계를 분할하는데 평균 형상 모델을 적용하는 것이다. 먼저, 에지 분포를 이용하여 프로브를 찾고, 프로브와 연결된 두 직선을 찾는다. 이 후에 이 정보를 이용하여 전립선 영상 위에 평균 형상을 위치시킨다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권13호
• /
• pp.5377-5383
• /
• 2015

Background: Participation is one of the major factors affecting the long-term success of population-based prostate cancer screening programs. The aim of this study was to explore strong factors linked to participation in prostate cancer screening among older Jordanian adults using the Health Belief Model (HBM). Materials and Methods: Data were obtained from Jordanian older adults, aged 40 years and over, who visited a comprehensive health care center within the Ministry of Health. A pilot test was conducted to investigate the internal consistency of the the Champion Health Belief Model Scale for prostate cancer screening and the clarity of survey questions. Sample characteristics and rates of participation in prostate cancer screening were examined using means and frequencies. Important factors associated with participation in prostate cancer screening were examined using bivariate correlation and multivariate logistic regression analysis. Results: About 13% of the respondents had adhered to prostate cancer screening guidelines over the previous decade. Four out of the seven HBM-driven factors (perceived susceptibility, benefits and barriers to PSA test, and health motivation) were statistically significant. Those with greater levels of susceptibility, benefits of PSA test and health motivation and lower levels of barriers to PSA testing were more likely to participate in prostate cancer screening. Family history, presence of urinary symptoms, age, and knowledge about prostate cancer significantly predicted the participation in prostate cancer screening. Conclusions: Health professionals should focus more on the four modifiable HBMrelated factors to encourage older adults to participate in prostate cancer screening. Intervention programs, which lower perceived barriers to PSA testing and increase susceptibility, benefits of PSA testing and health motivation, should be developed and implemented.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권5호
• /
• pp.1827-1831
• /
• 2015

Background: We generated a mouse model of prostate cancer based on the adult-prostate-specific inactivation of phosphatase and tensin homolog (PTEN) using the Cre-loxP system. The potential of our mice as a useful animal model was examined by evaluating the chemopreventive efficacy of the anti-androgen, chlormadinone acetate (CMA). Materials and Methods: Six-week-old mice were treated subcutaneously with $50{\mu}g/g$ of CMA three times a week for 9 or 14 weeks and sacrificed at weeks 15 and 20. Macroscopic change of the entire genitourinary tract (GUT) and histologically evident prostate gland tumor development were evaluated. Proliferation and apoptosis status in the prostate were examined by immunohistochemistry. Results: CMA triggered significant shrinkage of not only the GUT but also prostate glands at 15 weeks compared to the control (p=0.017 and p=0.010, respectively), and the trend became more marked after a further five-weeks of treatment. The onset of prostate adenocarcinoma was not prevented but the proliferation of cancer cells was inhibited by CMA, which suggested the androgen axis is critical for cancer growth in these mice. Conclusions: Conditional PTEN-deficient mice are useful as a preclinical model for chemoprevention studies and serve as a valuable tool for the future screening of potential chemopreventive agents.

• 정보처리학회논문지:소프트웨어 및 데이터공학
• /
• 제1권3호
• /
• pp.187-194
• /
• 2012

전립선암은 남자에게 가장 흔히 나타나는 암 중의 하나이며, 많은 나라에서 죽음에 이르게 하는 큰 요인이 되고 있다. 전립선암을 진단하고 치료하는 과정에서 비용이 싼 TRUS 영상이 사용된다. 그러나 전립선 경계의 정확한 구분이 요구되지만 어려운 문제이다. 그 이유는 경계가 불명확하고, 반점들이 많으며, 그레이 레벨의 범위가 작기 때문이다. 본 연구에서는 전립선의 평균 형상 모델과 불변의 특징을 이용하여 TRUS 영상에서 자동으로 전립선 분할하는 방법을 제안한다. 이 방법은 4 단계로 구성된다. 먼저, 에지 분포를 이용하여 프로브와 두개의 직선을 찾아낸다. 다음으로, 평균 형상 모델의 중앙에 위치한 3개의 전립선 패치를 획득한다. 이 패치는 전립선과 비전립선의 특징을 비교하기 위해 사용된다. 다음으로, 세 개의 패치와 각 블록들이 얼마나 대표 블록과 유사한지를 비교한다. 마지막으로, 앞 단계의 경계와 첫 단계에서 얻은 개략적 경계가 최종 분할에 사용된다. 이 방법의 유효성을 검증하기 위하여 실험을 하였으며, 인간 전문가에 의해 얻어진 경계와 비교하여 7.78% 미만의 차이로 경계를 얻을 수 있었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권16호
• /
• pp.7011-7023
• /
• 2015

Background: Prostate cancer is one of the most common cancers affecting men globally, constituting the sixth leading cause of cancer related death in males, and the eleventh leading cause of death from cancer in all age groups. In Jordan, prostate cancer is the third most common cancer in the male population, accounting for one third (6.2%) of cancer related deaths and in 2010 alone, 218 (9.4%) new cases were identified. Objective: To assess the effectiveness of different health education interventions aimed at enhancing knowledge, beliefs and intention to screen for prostate cancer. Materials and Methods: A literature search from January 2000 to April 2015 was conducted using the key words "prostate disease," "educational program," "knowledge," "prostate cancer," "demographic factors and prostate cancer," "knowledge and prostate cancer," "education for patients with prostate cancer," "factors that affect intention to screen," "knowledge, beliefs, and intention to screen for prostate cancer," "impact of prostate educational program on beliefs," and "impact of educational program on intention to screen." Results: Majority of studies reviewed indicated that men had low levels of knowledge regarding prostate cancer, and mild to moderate beliefs with good intention to screen for prostate cancer. Conclusions: Most studies indicated that men's knowledge levels about prostate cancer were poor and they had mild to moderate beliefs and intentions to screen for prostate cancer. Therefore, development of an assessment strategy based on the Health Belief Model seems essential. An effectively designed and implemented educational program can help identify the needs and priorities of the target population.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권5호
• /
• pp.1857-1863
• /
• 2015

Background: Alpha-methylacyl-CoA racemase(AMACR) is thought to play key roles in diagnosis and prognosis of prostate cancer. However, studies of associations between AMACR gene polymorphisms and prostate cancer risk reported inconsistent results. Therefore, we conducted the present meta-analysis to clarify the link between AMACR gene polymorphisms and prostate cancer risk. Materials and Methods: A literature search was performed in PubMed, Embase, China National Knowledge Infrastructure (CNKI), Wanfang and Weipu databases. Odds ratios (ORs) and 95% confidence intervals (95%CIs) were calculated to assess the strength of any association between AMACR polymorphisms and prostate cancer risk. Subgroup analyses by ethnicity, source of controls, quality control and sample size were also conducted. Results: Five studies covering 3,313 cases and 3,676 controls on five polymorphisms (D175G, M9V, S201L, K277E and Q239H) were included in this meta-analysis. Significant associations were detected between prostate cancer and D175G (dominant model: OR=0.89, 95%CI=0.80-0.99, P=0.04) and M9V (dominant model: OR=0.87, 95%CI=0.78-0.97, P=0.01) polymorphisms as well as that in subgroup analyses. We also observed significant decreased prostate cancer risk in the dominant model (OR=0.90, 95%CI=0.81-0.99, P=0.04) for the S201L polymorphism. However, K277E and Q239H polymorphisms did not appear to be related to prostate cancer risk. Conclusions: The current meta-analysis indicated that D175G and M9V polymorphisms of the AMACR gene are related to prostate cancer. The S201L polymorphism might also be linked with prostate cancer risk to some extent. However, no association was observed between K277E or Q239H polymorphisms and susceptibility to prostate cancer.

• 대한방사선기술학회지:방사선기술과학
• /
• 제38권4호
• /
• pp.437-442
• /
• 2015

전립선의 정확한 볼륨측정은 전립선암과 전립선비대의 진단, 치료 결정 및 예후 판정에 있어서 중요한 역할을 한다. 또한, 전립선암 선별검사에 사용하고 있는 혈청전립선특이항원(serum prostate-specific antigen)은 전립선의 볼륨과 서로 높은 상관관계를 보이기 때문에 이를 평가하기 위해서는 정확한 볼륨을 아는 것이 중요하다. 기존의 전립선 측정법이 다양하게 제시되고 있으나 전립선 모형 별 측정법에 대한 연구는 없었다. 본 연구에서는 다양한 모형의 팬텀을 제작하고 초음파를 이용하여 볼륨을 알아본 후 모형 별 측정위치를 찾아 새로운 측정방법을 제시하고자 한다. 초음파 검사를 통해 특징적인 전립선 모양 6개를 선정하였다. 이를 횡단과 종단영상을 참고하여 전립선 모형 6개를 제작하였다. 최적의 측정위치에서 각각 3회씩 반복측정 후 실제볼륨과 측정볼륨간의 유의성을 알아보기 위하여 Wilcoxon 부호순위 검정을 실시하였다. p값은 0.05이하일 때 유의한 것으로 정하였다. Axial 영상에서 돌출부위를 제외하고 안쪽으로 두고, Longitudinal 영상에서는 base와 apex의 오목한 부분에 측정 점을 놓았을 때 실제 전립선 크기와 일치도가 높았다. 실제볼륨과 측정볼륨간의 유의성은 p값 0.156으로 통계적으로 유의한 차이가 없었다. 전립선 axial 영상에서 전립선 이행대의 돌출이 심할 경우 돌출부위를 배제하고 측정하는 것이 실제 볼륨에 가까웠다. 또한 longitudinal영상에서는 apex부분이 가늘고 길어질 경우에 끝부분이 아닌 안쪽으로 측정 점을 잡아 그 점을 기준으로 타원을 그려 볼륨을 측정하는 것이 실제 볼륨에 가장 가까웠다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권11호
• /
• pp.4525-4530
• /
• 2015

Background: The MTHFR C677T polymorphism is a genetic alteration affecting an enzyme involved in folate metabolism, but its relationship to host susceptibility to prostate cancer remains uncertain. The aim of this study was to investigate the association between MTHFR C677T polymorphism and prostate cancer by performing a meta-analysis. Materials and Methods: Pubmed and Web of Science databases were searched for case-control studies investigating the association between MTHFR C677T polymorphism and prostate cancer. Odds ratios (OR) and 95% confidence intervals (95%CI) were used to assess any link. Results: A total of 22 independent studies were identified, including 10,832 cases and 11,993 controls. Meta-analysis showed that there was no obvious association between MTHFR C677T polymorphism and risk of prostate cancer under all five genetic models. There was also no obvious association between MTHFR C677T polymorphism and risk of prostate cancer in the subgroup analyses of Caucasians. In contrast, MTHFR C677T polymorphism was associated with increased risk for prostate cancer in Asians with the allele model (C vs G: OR=1.299, 95 %CI =1.121-1.506, P=0.001, $P_{heterogeneity}=0.120$, $I^2=45%$), additive genetic model (CC vs TT: OR =1.925, 95 % CI= 1.340-2.265, P=0.00, $P_{heterogeneity}=0.587$, $I^2=0.00%$), recessive model (CC vs TT+TC: OR= 1.708, 95 % CI=1.233-2.367, P=0.001, $P_{heterogeneity}=0.716$, $I^2=0.00%$), and heterozygote genetic model (CT vs TT: OR=2.193, 95 % CI =1.510-3.186, P=0.000, $P_{heterogeneity}=0.462$, $I^2=0.00%$). Conclusions: These results suggest that the MTHFR C677T polymorphism does not contribute to the risk of prostate cancer from currently available evidence in populations overall and Caucasians. However, the meta analysis indicates that it may play a role in prostate cancer development in Asians.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권1호
• /
• pp.63-68
• /
• 2013

Background: Tumor angiogenesis correlates with recurrence and appears to be a prognostic factor for both breast and prostate cancers. In the present study, we aimed to investigate the correlation of microvessel density (MVD), a measure of angiogenesis, with nuclear pleomorphism, mitotic count, and vascular invasion in breast and prostate cancers at preclinical and clinical levels. Methods: Samples from xenograft tumors of luminal B breast cancer and prostate adenocarcinoma, established by BT-474 and PC-3 cell lines, respectively, and commensurate human paraffin-embedded blocks were obtained. To determine MVD, specimens were immunostained for CD-34. Nuclear pleomorphism, mitotic count, and vascular invasion were determined using hematoxylin and eosin (H&E)-stained slides. Results: MVD showed significant correlations with nuclear pleomorphism (r=0.68, P=0.03) and vascular invasion (r=0.77, P=0.009) in breast cancer. In prostate cancer, MVD was significantly correlated with nuclear pleomorphism (r=0.75, P=0.013) and mitotic count (r=0.75, P=0.012). In the breast cancer xenograft model, a significant correlation was observed between MVD and vascular invasion (r=0.87, P=0.011). In the prostate cancer xenograft model, MVD was significantly correlated with all three parameters (nuclear pleomorphism, r=0.95, P=0.001; mitotic count, r=0.91, P=0.001; and vascular invasion, r=0.79, P=0.017; respectively). Conclusions: Our results demonstrate that MVD is correlated with nuclear pleomorphism, mitotic count, and vascular invasion at both preclinical and clinical levels. This study therefore supports the predictive value of MVD in breast and prostate cancers.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권9호
• /
• pp.4327-4330
• /
• 2012

The mouse double minute 2 (MDM2) gene plays a key role in the p53 pathway, and the SNP 309T/G single-nucleotide polymorphism in the promoter region of MDM2 has been shown to be associated with increased risk of cancer. However, no consistent results were found concerning the relationships between the polymorphism and prostate cancer risk. This meta-analysis, covering 4 independent case-control studies, was conducted to better understand the association between MDM2-SNP T309G and prostate cancer risk focusing on overall and subgroup aspects. The analysis revealed, no matter what kind of genetic model was used, no significant association between MDM2-SNP T309G and prostate cancer risk in overall analysis (GT/TT: OR = 0.84, 95%CI = 0.60-1.19; GG/TT: OR = 0.69, 95%CI = 0.43-1.11; dominant model: OR = 0.81, 95%CI= 0.58-1.13; recessive model: OR = 1.23, 95%CI = 0.95-1.59). In subgroup analysis, the polymorphism seemed more likely to be a protective factor in Europeans (GG/TT: OR = 0.52, 95%CI = 0.31-0.87; recessive model: OR = 0.58, 95%CI = 0.36-0.95) than in Asian populations, and a protective effect of the polymorphism was also seen in hospital-based studies in all models (GT/TT: OR = 0.74, 95%CI = 0.57-0.97; GG/TT: OR = 0.55, 95%CI = 0.38-0.79; dominant model: OR = 0.69, 95%CI = 0.54-0.89; recessive model: OR = 0.70, 95%CI = 0.51-0.97). However, more primary studies with a larger number of samples are required to confirm our findings.